| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 05/31/2006 | EP1662004A1 Method of efficiently constructing growth regulatory recombinant adenovirus vector and kit for the construction thereof |
| 05/31/2006 | EP1661999A1 A method of preparing epitopes chimeric gene vaccine |
| 05/31/2006 | EP1661995A1 Method of diagnosing, monitoring, staging, imaging and treating colon cancer |
| 05/31/2006 | EP1661990A1 Polypeptide specific to liver cancer, polynucleotide encoding the polypeptide and rna molecule inhibiting the expression of the polypeptide |
| 05/31/2006 | EP1661984A1 Method of differentiation from embryo-stem cell of primate to hematogenous cell |
| 05/31/2006 | EP1661898A1 Bicyclic piperazine compound and use thereof |
| 05/31/2006 | EP1661897A1 Pyrrolopyrimidinone derivative |
| 05/31/2006 | EP1661896A1 Pyrrolopyrimidinethione derivative |
| 05/31/2006 | EP1661889A1 Chemokine receptor antagonist and medical use thereof |
| 05/31/2006 | EP1661584A1 Use of conjugates of amatoxins and phallotoxins with macromolecules for cancer and inflammation therapy |
| 05/31/2006 | EP1661582A1 Cancer metastasis inhibitor |
| 05/31/2006 | EP1661574A1 Beta-hydroxy short to medium chain fatty acid polymer |
| 05/31/2006 | EP1660664A1 Poxvirus vector encoding prostate specific antigens for treatment of prostate cancer |
| 05/31/2006 | EP1660636A2 Anti-cancer vaccines |
| 05/31/2006 | EP1660535A2 Techniques and compositions for the diagnosis and treatment of cancer (muc1) |
| 05/31/2006 | EP1660513A2 A ca6 antigen-specific cytotoxic conjugate and methods of using the same |
| 05/31/2006 | EP1660504A1 Thienopyridine-phenylacet amides and their derivatives useful as new anti-angiogenic agents |
| 05/31/2006 | EP1660503A1 Naphthalene carboxamides and their derivatives useful as new anti-angiogenic agents |
| 05/31/2006 | EP1660500A1 Substituted imidazopyrimidines for the prevention and treatment of cancer |
| 05/31/2006 | EP1660487A1 Pyrrole compositions useful as inhibitors of c-met |
| 05/31/2006 | EP1660477A1 Novel farnesyl protein transferase inhibitors as antitumor agents |
| 05/31/2006 | EP1660475A1 Pyrimidylpyrrole derivatives active as kinase inhibitors |
| 05/31/2006 | EP1660474A1 Substituted thiophenes and uses thereof |
| 05/31/2006 | EP1660473A2 Xanthones, thioxanthones and acridinones as dna-pk inhibitors |
| 05/31/2006 | EP1660467A2 Aminofurazan compounds as protein kinase inhibitors |
| 05/31/2006 | EP1660444A2 Metal complexes of n-heterocyclic carbenes as radiopharmaceuticals and antibiotics |
| 05/31/2006 | EP1660186A2 Humanization of antibodies |
| 05/31/2006 | EP1660134A2 Conjugates of hydroxyalkyl starch and g-csf |
| 05/31/2006 | EP1660127A1 Antibodies to c-met |
| 05/31/2006 | EP1660126A1 Agonists or antagonists of the clucocorticoid-induced tumour necrosis factor receptor (gitr) or its ligand for the treatment of immune disorders, infections and cancer |
| 05/31/2006 | EP1660100A1 Anti-tumor formulations comprising defibrotide alone or in combination with other anti-tumor agents |
| 05/31/2006 | EP1660095A2 Tricyclic parp inhibitors |
| 05/31/2006 | EP1660087A2 Quinolinone derivatives as inhibitors of c-fms kinase |
| 05/31/2006 | EP1660085A1 Pyridylpyrrole derivatives active as kinase inhibitors |
| 05/31/2006 | EP1660060A2 Pharmaceutical compositions for preventing breast and ovarian cancer |
| 05/31/2006 | EP1660041A1 Non-polar photosensitizer formulations for photodynamic therapy |
| 05/31/2006 | EP1660040A1 In vivo targeting of dendritic cells |
| 05/31/2006 | EP1660026A2 Treatment for cd5+ b cell lymphoma |
| 05/31/2006 | EP1660010A2 Compositions and methods for restoring sensitivity to treatment with her2 antagonists |
| 05/31/2006 | EP1441716B1 Alkane diol derivatives as therapeutic agents for the treatment of bone conditions |
| 05/31/2006 | EP1420824B1 Sulfonated chlorines as photosensitizer |
| 05/31/2006 | EP1419178B1 Somatostatin analogues and their use somatostatin analogues binding to all somatostatin receptor and their use |
| 05/31/2006 | EP1408960B1 Benz-indole and benzo-quinoline derivatives as prodrugs for tumour treatment |
| 05/31/2006 | EP1363504B1 Process for the fractionation of cereal brans |
| 05/31/2006 | EP1352061B1 Method for inhibiting the expression of a target gene |
| 05/31/2006 | EP1346226B1 Screening method based on siah-numb interaction |
| 05/31/2006 | EP1345922B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/31/2006 | EP1318997B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/31/2006 | EP1317449B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/31/2006 | EP1317444B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/31/2006 | EP1313855B1 Truncated bard1 protein, and its diagnostic and therapeutic uses |
| 05/31/2006 | EP1296931B1 Polyamine analogues as cytotoxic agents |
| 05/31/2006 | EP1272223B1 Therapeutic and diagnostic ligand systems comprising transport molecule binding properties and medicaments containing the same |
| 05/31/2006 | EP1270579B1 Process for producing camptothecin |
| 05/31/2006 | EP1270570B1 Amide compounds and use thereof |
| 05/31/2006 | EP1268798B1 Anti-angiogenic properties of vascostatin and fragments or variants thereof |
| 05/31/2006 | EP1235851B1 Regulators of the hedgehog pathway, compositions and uses related thereto |
| 05/31/2006 | EP1175489B1 Oligonucleotides containing an antisense sequence stabilised by a secondary structure and pharmaceutical compositions containing same |
| 05/31/2006 | EP1163238B1 Chemokine recpetor binding heterocyclic compounds |
| 05/31/2006 | EP1115426B1 Method of diagnosing, monitoring, staging, imaging and treating gynecologic cancers |
| 05/31/2006 | EP1073682B1 Heparanase specific molecular probes and their use in research and medical applications |
| 05/31/2006 | EP1067908B1 Taxane microemulsions |
| 05/31/2006 | EP0891426B1 Human bikunin |
| 05/31/2006 | EP0689593B1 Inhibition of selected tumor growth with recombinant viral vector |
| 05/31/2006 | CN1780919A Methods and products based on oligomerization of stress proteins |
| 05/31/2006 | CN1780846A Bifunctional heterocyclic compounds and methods of making and using the same |
| 05/31/2006 | CN1780840A Pyrazolo 1,5-a pyrimidine derivatives |
| 05/31/2006 | CN1780835A Novel fused heterocycles and uses thereof. |
| 05/31/2006 | CN1780830A Aniline derivatives, their manufacture and use as pharmaceutical agents |
| 05/31/2006 | CN1780821A Heterocyclic kinase inhibitors. |
| 05/31/2006 | CN1780820A Quinoxalinone-3- one derivatives as orexin receptor antagonists |
| 05/31/2006 | CN1780634A Methods and compositions using gonadotropin hormone releasing hormone |
| 05/31/2006 | CN1780632A Therapy for primary and metastatic cancers |
| 05/31/2006 | CN1780629A Medicinal compositions comprising n-(3-chloro-1h-indol-7-yl)-4-sulfamoylbenzenesulfonamide and further cytostatics |
| 05/31/2006 | CN1780627A Combinations for the treatment of diseases involving cell proliferation, migration or apoptosis of myeloma cells, or angiogenesis |
| 05/31/2006 | CN1778918A SiRNA for inhibiting Stat3 gene expression and preparation thereof |
| 05/31/2006 | CN1778824A Multiple homogeneous tremella polysaccharide, its extraction and medicinal composition with this compound as active components |
| 05/31/2006 | CN1778823A Homogeneous tremella polysaccharide modifier with multiple biological activity, its production and preparation containing them |
| 05/31/2006 | CN1778822A Monoclonal antibody of C-shaped agglutinin receptor L1, its production and use thereof |
| 05/31/2006 | CN1778810A Ginseng dialcohol hypometaalcohol derivative, itspreparation and use |
| 05/31/2006 | CN1778802A Crystal form of Peimeiqusai disodium and its preparation |
| 05/31/2006 | CN1778389A Medicine for treating tumor and use thereof |
| 05/31/2006 | CN1778380A Extraction of Job's tears seeds, its component and curative effect |
| 05/31/2006 | CN1778324A Effective part of nightshadeleaf ironweed for antiscolic medicines and its preparation and use |
| 05/31/2006 | CN1778294A Butin and its derivative and its use in preparation of pigmental metabolic disease medicine |
| 05/31/2006 | CN1257976C Improved vaccines |
| 05/31/2006 | CN1257915C Adherence peptide specific to tissue of liver cancer obtained through sieve method in rivo and usage |
| 05/31/2006 | CN1257878C Pterocarya stenoptera quinone, its preparation and use |
| 05/31/2006 | CN1257751C Method for regulating replication of nonreplication adenovirus |
| 05/31/2006 | CN1257725C Medicine for treating malignant tumor and its preparation method |
| 05/31/2006 | CN1257714C Injection of liposome of daunorubicin or hydrochloric daunorubicin and preparation method |
| 05/31/2006 | CN1257708C Modified water-soluble medicine and vaccine embedded macromolecule microsphere preparation method |
| 05/30/2006 | US7053215 For therapy of inflammatory and immunoregulatory disorders and diseases, such as multiple sclerosis, rheumatoid arthritis and type I diabetes |
| 05/30/2006 | US7053207 L-ribo-LNA analogues |
| 05/30/2006 | US7053186 Protein for use in diagnosis and treatment of cancer |
| 05/30/2006 | US7053185 contacting alpha-lactalbumin (in molten globule-like state) with fatty acids and lipids found in a milk fraction containing casein obtained from humans; antibacterial agents; anticancer agents |
| 05/30/2006 | US7053123 Substituted (e)-styryl benzylsulfones for treating proliferative disorders |
| 05/30/2006 | US7053117 Substituted 4H-chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 05/30/2006 | US7053114 A modulator controls the activity of protein kinases, tyrosine kinase; enzyme inhibitors; nontoxic, solubility, formulability, bioavailability; cancer, diabetes, hepatic cirrhosis, atherosclerosis, angiogenesis, autoimmune disease and renal disease |
| 05/30/2006 | US7053113 Mannich base prodrugs of 3-(pyrrol-2-yl-methylidene)-2-indolinone derivatives |